Alphabet Inc. Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001652044
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2025 · 29 positions · Total reported value $2.58B · Top-10 concentration 92.8% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 29.0% · 3 new · 3 cut · 3 exited
Active Share (vs S&P 500): 99.6% · vs QQQ: 96.0% — share of the book that differs from index weights (higher = more active) · ranking
In its Q4 2025 13F filing, Alphabet Inc. disclosed 29 equity positions with a combined reported value of $2.58B. The filing implies a focused portfolio: its ten largest positions account for 92.8% of reported value. HoldingsHub classifies the profile as Mid / Focused / Technology Tilt / High Turnover.
The largest disclosed positions as of Q4 2025 were ASTS ($649.57M), PL ($629.91M), RVMD ($266.44M). By sector, the heaviest allocations are Technology 52.7%, Consumer Discretionary 25.2%. Versus the prior quarter, allocation shifted toward Consumer Discretionary (+7.0pp), Technology (+1.4pp) and away from Other (-8.3pp).
Versus the prior quarter, Alphabet Inc. opened 3 new positions, trimmed 3 and fully exited 3, a turnover rate of 29.0% of positions. The portfolio's overlap with the prior quarter was 78% of names.
Of the 3 positions fully exited versus the prior quarter, the largest were MTSR ($197.99M), DNTH ($8.21M), FHTX ($2.45M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2025)
No new positions this quarter.
Fully Exited (vs previous quarter)
- MTSR METSERA INC · prev qtr: $197.99M
- DNTH DIANTHUS THERAPEUTICS INC · prev qtr: $8.21M
- FHTX FOGHORN THERAPEUTICS INC · prev qtr: $2.45M
- TSHA TAYSHA GENE THERAPIES INC · prev qtr: $2.10M
- TCRX TSCAN THERAPEUTICS INC · prev qtr: $1.96M
- BRNS VACCITECH PLC · prev qtr: $1.89M
- GUTS FRACTYL HEALTH INC · prev qtr: $1.05M
- ALEC ALECTOR INC · prev qtr: $520.56K
Insider Transactions (Form 4)
Latest Alphabet Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
| Transaction date | Activity | Security | Shares | Price | Filing |
|---|---|---|---|---|---|
| 2026-07-28 | Sell | Ethos Technologies Inc. | 118,138 | $18.90 | SEC filing |
| 2026-07-28 | J | Ethos Technologies Inc. | 118,138 | — | SEC filing |
| 2026-07-27 | Sell | Ethos Technologies Inc. | 196,931 | $19.46 | SEC filing |
| 2026-07-27 | J | Ethos Technologies Inc. | 196,931 | — | SEC filing |
| 2026-07-24 | Sell | Ethos Technologies Inc. | 23,417 | $18.88 | SEC filing |
| 2026-07-24 | J | Ethos Technologies Inc. | 23,417 | — | SEC filing |
| 2026-07-23 | Sell | Ethos Technologies Inc. | 63,297 | $19.06 | SEC filing |
| 2026-07-23 | J | Ethos Technologies Inc. | 63,297 | — | SEC filing |
Fund Profile
Alphabet Inc. is an SEC-registered 13F filer. As of Q2 2026 it reported 28 US equity positions with a combined value of $99.08B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 28 positions · $99.08B reported value (Q2 2026)
- Top 10 holdings = 99.5% of reported value
- Largest position: SPCX (SPACE EXPLORATION TECHN CORP) at 95.0%
- Average position size: $3.54B
Sector Tilt
- Information Technology 97.4%
- Health Care 0.9%
- Consumer Discretionary 0.8%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 3 new, 4 reduced, 1 exited
- 21 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
8.94M | $649.57M | 25.18% | Hold | |
| 2 |
|
31.94M | $629.91M | 24.42% | Hold | |
| 3 |
|
3.35M | $266.44M | 10.33% | Reduce | |
| 4 |
|
1.96M | $214.33M | 8.31% | Hold | |
| 5 |
|
16.21M | $198.53M | 7.70% | Hold | |
| 6 |
|
7.03M | $115.29M | 4.47% | Hold | |
| 7 |
|
2.72M | $102.26M | 3.96% | Hold | |
| 8 |
|
1.55M | $91.59M | 3.55% | Hold | |
| 9 |
|
1.04M | $68.82M | 2.67% | Hold | |
| 10 |
|
1.39M | $57.53M | 2.23% | Reduce | |
| 11 |
|
16.56M | $57.47M | 2.23% | Hold | |
| 12 |
|
2.82M | $35.35M | 1.37% | Hold | |
| 13 |
|
1.57M | $13.27M | 0.51% | Hold | |
| 14 |
|
241.26K | $12.22M | 0.47% | Hold | |
| 15 |
|
744.95K | $11.68M | 0.45% | Reduce | |
| 16 |
|
2.81M | $11.45M | 0.44% | Hold | |
| 17 |
|
293.26K | $9.03M | 0.35% | Hold | |
| 18 |
|
321.60K | $8.91M | 0.35% | Hold | |
| 19 |
|
215.58K | $8.06M | 0.31% | Hold | |
| 20 |
|
481.99K | $6.93M | 0.27% | Hold | |
| 21 |
|
22.71K | $2.95M | 0.11% | Hold | |
| 22 |
|
23.20K | $2.36M | 0.09% | Hold | |
| 23 |
|
889.98K | $2.07M | 0.08% | Hold | |
| 24 |
|
698.26K | $1.39M | 0.05% | Hold | |
| 25 |
|
898.72K | $880.75K | 0.03% | Hold | |
| 26 |
|
915.71K | $650.15K | 0.03% | Hold | |
| 27 |
|
189.12K | $633.56K | 0.03% | Hold | |
| 28 |
|
14.26K | $161.30K | 0.01% | Hold | |
| 29 |
|
383 | $62.76K | 0.00% | Hold | |
FAQ
What did Alphabet Inc. buy in 2025-Q4?
In its 2025-Q4 13F filing, Alphabet Inc. reported 29 equity positions worth $2.58B in aggregate; its largest disclosed positions were ASTS ($649.57M), PL ($629.91M), RVMD ($266.44M).
How large is Alphabet Inc.'s portfolio?
Alphabet Inc. reported $2.58B of long equity holdings across 29 positions as of 2025-Q4. Top-10 holdings account for 92.8% of reported value.
What is Alphabet Inc.'s investment style?
HoldingsHub classifies the portfolio as Mid / Focused / Technology Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.